↓ Skip to main content

Cochrane Database of Systematic Reviews

Ocrelizumab for multiple sclerosis

Overview of attention for article published in Cochrane database of systematic reviews, May 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

blogs
1 blog
twitter
13 tweeters
facebook
2 Facebook pages

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
27 Mendeley
Title
Ocrelizumab for multiple sclerosis
Published in
Cochrane database of systematic reviews, May 2022
DOI 10.1002/14651858.cd013247.pub2
Pubmed ID
Authors

Mengbing Lin, Jian Zhang, Yueling Zhang, Jiefeng Luo, Shengliang Shi

Twitter Demographics

The data shown below were collected from the profiles of 13 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 4%
Unknown 26 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 15%
Researcher 4 15%
Other 3 11%
Student > Ph. D. Student 3 11%
Student > Postgraduate 2 7%
Other 3 11%
Unknown 8 30%
Readers by discipline Count As %
Medicine and Dentistry 11 41%
Pharmacology, Toxicology and Pharmaceutical Science 2 7%
Neuroscience 2 7%
Unspecified 1 4%
Computer Science 1 4%
Other 0 0%
Unknown 10 37%

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 October 2022.
All research outputs
#2,194,684
of 22,440,112 outputs
Outputs from Cochrane database of systematic reviews
#4,712
of 12,244 outputs
Outputs of similar age
#44,730
of 341,874 outputs
Outputs of similar age from Cochrane database of systematic reviews
#9
of 19 outputs
Altmetric has tracked 22,440,112 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,244 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.1. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 341,874 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.